TITLE

Three Things

PUB. DATE
August 2011
SOURCE
Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to the U.S. pharmaceutical industry including the adoption of digital technologies by pharmaceutical companies, the continuing debate regarding pharmaceuticals and managed care, and the decision of Pfizer Inc. to sell its veterinary unit, while keeping its generics unit.
ACCESSION #
63988779

 

Related Articles

  • BITTER PILLS FOR PHARMA. Newman, Melanie // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/25/2010, Vol. 341 Issue 7774, p632 

    The article discusses the plan of the U.S. government to implement radical measures to address the illegal marketing of drugs by pharmaceutical companies in 2010. According to the author, pharmaceutical companies agree to pay fines to settle their illegal drug marketing cases but they continue...

  • One Hit Wonders. Lowe, Derek B. // Contract Pharma;May2014, Vol. 16 Issue 4, p26 

    The article provides information regarding the condition of the pharmaceutical industry in the U.S. It highlights critical issues experiencing several drug companies in the country which include buyouts, mergers, and drug discovery. An issue concerning Pfizer Inc.'s series of humungous mergers...

  • Hooked on Drug Profits.  // America;12/19/2011, Vol. 205 Issue 19, p4 

    The article focuses on the increasing trend in pharmaceutical companies of the U.S. to extend patent protections of their popular drugs and informs about the efforts being made by Pfizer to retain its market share after the patent for its cholesterol-reducing drug Lipitor expired.

  • UNITED STATES PHARMACEUTICALS.  // Acquisdata Industry SnapShot: United States - Pharmaceuticals;11/30/2015, Issue 3844, p1 

    An industry report of U.S. pharmaceutical industry is presented from publisher Acquisdata, with topics including Pfizer, allergan deal, budget for pharma research, Glaxo Smith Kline research updates, and profiles of companies such as AstraZeneca Ltd. and Sanofi Ltd.

  • FINALISTS.  // Medical Marketing & Media;Sep2011, Vol. 46 Issue 9, p68 

    The article lists the finalists for the MM&M Awards 2011 in the U.S. in different categories including Pacific Communications Inc. and Allergan Inc. for botox, Draftfcb Healthcare and Cephalon Inc. for Nuvigil, and Blue Diesel and Merck & Co. Inc. for Merck vaccines.

  • WHY YOU SHOULD BLAME WALL STREET FOR PHARMA'S STARTUP PROBLEM. Primack, Dan // Fortune;12/12/2011, Vol. 164 Issue 9, p82 

    The article discusses a threat to the development of new drugs in the U.S. Some drug companies including Pfizer are cutting their research-and-development budgets, preferring to buy small pharmaceutical startups rather than fund drug development themselves. However, venture-capital firms are...

  • Update.  // Medical Marketing & Media;Nov2012, Vol. 47 Issue 11, p13 

    The article offers updates in the U.S. pharmaceutical industry including the use of social media by Pfizer Inc., the appointment of Cathy Wolfe as president of Wolters Kluwer's medical research division, and a survey about the influence of online tools on consumers' choice of healthcare services.

  • Ad campaign on aging gets hipper with new acronym. NEGGERS CRESCIONI, XAVIRA // Caribbean Business;7/24/2014, Vol. 42 Issue 28, p41 

    A review is offered for the advertising campaign of American biopharmaceutical company Pfizer Inc.

  • CHAPTER 92: LARGEST PHARMACEUTICAL COMPANIES. Miller, Richard K.; Washington, Kelli // Healthcare Business Market Research Handbook;2012, p385 

    A list of the top pharmaceutical corporations in terms of U.S. prescription sales in 2010 is presented including Pfizer, Merck & Co. and AstraZeneca.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics